Technology Selection for Enhancing Bioavailability

Compounds that require bioavailability enhancement to achieve target absorption are increasingly common in current pipelines. This webinar focuses on the rationale for selecting technologies that enable progression of such compounds, based on compound’s physical properties (e.g., melt and glass-transition temperatures, Log P) and product specifications (e.g., dose, pharmacokinetics, permeability). Case studies are presented that illustrate this process of technology and formulation selection.